FoxO proteins and cardiac pathology

Albert Wong1, Elizabeth A Woodcock

  • 1Molecular Cardiology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.

Insights

Forkhead box O (FoxO) transcription factors regulate diverse cellular functions. Their role in heart pathology, beyond development and cardioprotection, requires further investigation to understand their full impact.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cardiovascular Research

Background:

  • Forkhead box O (FoxO) transcription factors orchestrate critical cellular processes including apoptosis, survival, growth inhibition, and glucose metabolism.
  • The regulation of FoxO proteins is intricate, involving post-translational modifications like phosphorylation, ubiquitination, and acetylation, alongside interactions with other regulatory proteins.
  • In the heart, FoxO proteins are implicated in limiting hypertrophy during development and in mediating cardioprotection via interactions with silent information regulator 1 (Sirt1).

Purpose of the Study:

  • To explore the broader spectrum of cellular responses regulated by FoxO proteins.
  • To investigate the potential, yet unelucidated, pathological roles of FoxO family members in cardiac conditions.

Main Methods:

  • Review and synthesis of existing literature on FoxO transcription factors and their roles in cellular and cardiac physiology.
  • Analysis of regulatory mechanisms governing FoxO activity, including post-translational modifications and protein-protein interactions.
  • Examination of evidence linking FoxO regulators to cardiac pathology.

Main Results:

  • FoxO proteins control a wide array of cellular functions, demonstrating significant versatility in biological responses.
  • Complex regulatory networks involving phosphorylation, ubiquitination, acetylation, and interactions with other factors modulate FoxO activity.
  • Established roles in cardiac development and Sirt1-mediated cardioprotection highlight FoxO's importance in the heart.

Conclusions:

  • The multifaceted roles of FoxO proteins extend beyond their known functions in the heart.
  • Given their involvement in various cellular processes and known cardiac functions, further research is warranted to fully elucidate the pathological implications of FoxO family members in cardiovascular disease.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...